Randomized Comparison of Intra-Arterial Chemotherapy Versus Intra-Arterial Chemotherapy and Gelfoam Embolization for Treatment of Advanced Cervical Carcinoma

Abstract

Group B and C patients had better tumor reduction than those in group A. Fewer hematologic complications occurred in group C patients compared with group B.

Effect of Interventional Therapy on the Expression of Survivin mRNA in Cervical Cancer

“…Recently, with the application of neoadjuvant chemotherapy (NAC) and interventional therapy in gynecology, the prognosis of cervical cancer has been largely improved, such as increased survival time (2); improvement of sexual activity and bladder and bowel dysfunction (3) and even fertility persistence (4,5). After NAC and interventional therapy, most of those patients were able to undergo further treatment, Nowadays, the evaluation of the effect of interventional therapy on cervical cancer is primarily through pathology and pharmacokinetics (6)(7)(8). Unfortunately, limited information about the right time point for further treatment after interventional therapy is available.…”

Prognostic factors influencing the survival of patients with carcinoma of the gastric cardia receiving preoperative interventional embolization chemotherapy

“…Furthermore, interventional infusion of chemotherapeutic agents directly into the left gastric artery can have several advantages: first, the drug concentration in the tumor region is much higher compared with systemic intravenous infusion; second, it avoids metabolism or plasma protein binding of the chemotherapy drugs before they come into contact with the tumor cells; third, the drug concentration in other organs is much lower compared to that in intravenous chemotherapy. Therefore, interventional embolization chemotherapy (IEC) has a strong anti-cancer effect and can significantly reduce toxicity in comparison with systemic chemotherapy [ 13 , 14 ].…”